CD86 and neoplasm: Moreover, following treatment with the combination of SUP3 and Flt3L, CD103 + cDC1s within the tumor continued to exhibit high expression of co-stimulatory molecules, such as CD40, CD80, and CD86 expression (Fig. 7D).